SPECIFIC INHIBITION OF A PRIMER-DEPENDENT NUCLEOTIDE CHAIN ELONGATION REACTION BY THE RIFAMYCIN DERIVATIVE AF/013JACOB ST; ROSE KM; GLASER JM et al.1974; ARCH. BIOCHEM. BIOPHYS.; U.S.A.; DA. 1974; VOL. 164; NO 2; PP. 771-773; BIBL. 14REF.Article

IN VITRO INHIBITION OF RNA-INSTRUCTED DNA POLYMERASERAINER H; LUTZ D; STACHER A et al.1975; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1975; VOL. 25; NO 5; PP. 735-737; ABS. ALLEM.; BIBL. 12REF.Article

THE MODIFICATION OF DNA-DEPENDENT RNA POLYMERASE FROM ESCHERICHIA COLI BY AN ALKYLATING DERIVATIVE OF RIFAMYCIN SVSTENDER W; STUTZ AA; SCHEIT KH et al.1975; EUROP. J. BIOCHEM.; GERM.; DA. 1975; VOL. 56; NO 1; PP. 129-136; BIBL. 33 REF.Article

DETERGENT EFFECTS ON A REVERSE TRANSCRIPTASE ACTIVITY AND ON INHIBITION BY RIFAMYCIN DERIVATIVESTHOMPSON FM; LIBERTINI LJ; ROSS UR et al.1972; SCIENCE; U.S.A.; DA. 1972; VOL. 178; NO 4060; PP. 505-507; BIBL. 8 REF.Serial Issue

RIFAMYCIN ANTIBIOTICS: INHIBITORS OF RAUSCHER MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE AND OF PURIFIED DNA POLYMERASES FROM HUMAN NORMAL AND LEUKEMIC LYMPHOBLASTSYANG SS; HERRERA FM; SMITH RG et al.1972; J. NATION. CANCER INST.; U.S.A.; DA. 1972; VOL. 49; NO 1; PP. 7-25; BIBL. 18REF.Serial Issue

INHIBITION OF DNA POLYMERASES ALPHA AND GAMMA BY RIFAMYCIN DERIVATIVE AF/013YAGURA T; KOZU T; SENO T et al.1981; J. BIOCHEM. (TOKYO); ISSN 0021-924X; JPN; DA. 1981; VOL. 90; NO 5; PP. 1397-1403; BIBL. 23 REF.Article

SUSCEPTIBILITY OF SALMONELLA TYPHI TO RIFAMYCINS AND NOVOBIOCINSHANSON DC; LEUNG T.1976; J. ANTIMICROB. CHEMOTHERAPY; G.B.; DA. 1976; VOL. 2; NO 1; PP. 81-86; BIBL. 1 P.Article

MECHANISM OF ACTION OF RIFAMAZINE, A MEMBER OF A NEW CLASS OF (DIMERIC) RIFAMYCINSFIETTA AM; SILVESTRI LG.1975; EUROP. J. BIOCHEM.; GERM.; DA. 1975; VOL. 52; NO P. 203-400; PP. 391-400; BIBL. 44REF.Article

THE RIFAMYCIN DERIVATIVE AF/013 IS CYTOLYTIC.SCHEER U.1975; MOLEC. PHARMACOL.; U.S.A.; DA. 1975; VOL. 11; NO 6; PP. 883-888; BIBL. 21 REF.Article

INTERACTION BETWEEN MURINE TYPE-C VIRUS RNA-DIRECTED DNA POLYMERASE AND RIFAMYCIN DERIVATIVESWU AM; GALLO RC.1974; BIOCHIM. BIOPHYS. ACTA; PAYS-BAS; DA. 1974; VOL. 340; NO 4; PP. 419-436; BIBL. 37REF.Article

A GENETIC APPROACH TO THE BIOSYNTHESIS OF THE RIFAMYCIN-CHROMOPHORE IN NOCARDIA MEDITERRANEI. V: STUDIES ON THE BIOGENETIC ORIGIN OF 3-SUBSTITUENTS = APPROCHE GENETIQUE A LA BIOSYNTHESE DU CHROMOPHORE DE LA RIFAMYCINE CHEZ NOCARDIA MEDITERRANEI. V: ETUDES SUR L'ORIGINE BIOGENETIQUE DES SUBSTITUANTS EN 3TRAXLER P; GHISALBA O.1982; JOURNAL OF ANTIBIOTICS; ISSN 0021-8820; JPN; DA. 1982; VOL. 35; NO 10; PP. 1361-1366; BIBL. 23 REF.Article

ELECTRONEGATIVE GROUPS AT C-3 OF RIFAMYCIN S ENHANCE ITS ACTIVITY TOWARD DNA-DEPENDENT RNA POLYMERASEDAMPIER MF; WHITLOCK AW JR.1975; J. AMER. CHEM. SOC.; U.S.A.; DA. 1975; VOL. 97; NO 21; PP. 6254-6256; BIBL. 19 REF.Article

EFFECT OF TWO RIFAMYCIN DERIVATIVES ON THE ROUS SARCOMA VIRUS TRANSFORMATION SYSTEMBARLATI S; VIGIER P.1972; J. GEN. VIROL.; G.B.; DA. 1972; VOL. 17; NO 2; PP. 221-225; BIBL. 18REF.Serial Issue

DIFFERENTIAL SUSCEPTIBILITY OF SPLEEN FOCUS-FORMING VIRUS AND MURINE LEUKEMIA VIRUSES TO ANSAMYCIN ANTIBIOTICS.HOROSZEWICZ JS; LEONG SS; CARTER WA et al.1977; ANTIMICROB. AGENTS CHEMOTHERAPY; U.S.A.; DA. 1977; VOL. 12; NO 1; PP. 4-10; BIBL. 28 REF.Article

INHIBITION OF INFECTIOUS ROUS SARCOMA VIRUS PRODUCTION BY A RIFAMYCIN DERIVATIVESZABO C; BISSELL MJ; CALVIN M et al.1976; J. VIROL.; U.S.A.; DA. 1976; VOL. 18; NO 2; PP. 445-453; BIBL. 32 REF.Article

BIOCHEMICAL SUPPRESSION OF TUMOR VIRUS ACTIVITYGREEN M; GERARD GF; GRANDGENETT DP et al.1974; CANCER; U.S.A.; DA. 1974; VOL. 34; NO 4 SUPPL.; PP. 1427-1438; BIBL. 16 REF.Article

SYNERGISTIC EFFECT OF RIFAMYCIN DERIVATIVES AND AMPHOTERICINB ON VIRAL TRANSFORMATION OF A MURINE CELL LINE = EFFET SYNERGIQUE DES DERIVES DE RIFAMYCINE ET DE L'AMPHOTERICINEB SUR LA TRANSFORMATION VIRALE D'UNE LIGNEE CELLULAIRE MURINEHACKETT AJ; SYLVESTER SS; JOSS UR et al.1972; PROC. NATION. ACAD. SCI.; U.S.A.; DA. 1972; VOL. 69; NO 12; PP. 3653-3654; BIBL. 11REF.Serial Issue

ACTIVITY OF THREE NEW RIFAMYCIN DERIVATES ON THE EXPERIMENTAL INFECTION BY MYCOBACTERIUM LEPRAE.PATTYN SR; SAERENS EJ.1977; ANN. SOC. BELGE MED. TROP.; BELG.; DA. 1977; VOL. 57; NO 3; PP. 169-173; ABS. NEERL. FR.; BIBL. 3 REF.Article

DETERMINATION OF THE SOLUTION CONFORMATION OF RIFAMYCIN S AND DERIVATIVES BY NUCLEAR MAGNETIC RESONANCE.CASEY ML; WHITLOCK HW.1975; J. AMER. CHEM. SOC.; U.S.A.; DA. 1975; VOL. 97; NO 21; PP. 6231-6236; BIBL. 26 REF.Article

In vitro observations on the suitability of new rifamycins for the intermittent chemotherapy of tuberculosisDICKINSON, J. M; MITCHISON, D. A.Tubercle. 1987, Vol 68, Num 3, pp 183-193, issn 0041-3879Article

Identification of urinary metabolites of rifamycin LM 427 in manVIGEVANI, A; BALLABIO, M; GIOIA, B et al.Journal of antibiotics (Tokyo. 1968). 1985, Vol 38, Num 12, pp 1799-1802, issn 0021-8820Article

In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteriaDICKINSON, J. M; MITCHISON, D. A.Tubercle. 1987, Vol 68, Num 3, pp 177-182, issn 0041-3879Article

Novel rifamycins. IV: 3-aminomethylazinomethylrifamycins, a new class of rifamycins, endowed with remarkable antibacterial activityMARSILI, L; FRANCESCHI, G; BALLABIO, M et al.Journal of antibiotics (Tokyo. 1968). 1984, Vol 37, Num 10, pp 1209-1212, issn 0021-8820Article

31-Homorifamycin W, a novel metabolite from Amycolatopsis mediterraneiNAN-JIN WANG; BAO-LING HAN; YAMASHITA, N et al.Journal of antibiotics (Tokyo. 1968). 1994, Vol 47, Num 5, pp 613-615, issn 0021-8820Article

Page / 3